TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $91,793,000 | -0.5% | 5,227,376 | -45.0% | 1.21% | -2.3% |
| Q2 2021 | $92,247,000 | +12.1% | 9,510,000 | +24.2% | 1.24% | +1.6% |
| Q1 2021 | $82,258,000 | +17.0% | 7,659,000 | +60.2% | 1.22% | +13.0% |
| Q4 2020 | $70,335,000 | +54.8% | 4,781,448 | +49.6% | 1.08% | +21.4% |
| Q3 2020 | $45,429,000 | +120.5% | 3,197,008 | +25.5% | 0.89% | +98.4% |
| Q2 2020 | $20,605,000 | – | 2,547,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
| Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
| COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
| Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
| Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
| ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
| NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
| Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
| Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |